Therapeutic resistance and tumor recurrence is common in lung cancer.
Cancer stem cells (CSCs) have the ability to self-renew and differentiate.
CSCs display robust intrinsic resistance to chemotherapy.
Targeting CSCs may enhance tumor response and prevent relapse in NSCLC patients.
Further studies are warranted in the targeting of resistant tumorigenic lung CSCs.